$NKTR 3 SEC Filings

Filed On	Filing
26 May 2026	Form 3: Rubinstein Linda M, Interim CFO No securities owned
14 Mar 2024	Form 3: Deep Track Capital, Lp, 10% owner and 2 others Holds 18,400,000 shares of Common Stock
25 Apr 2023	Form 3: Gardiner Sandra A., Chief Financial Officer No securities owned
15 Nov 2021	Form 3: Brainard Diana, Director No securities owned
08 Apr 2020	Form 3: Wilson Mark Andrew, SVP & General Counsel Holds 53,947 shares of Common Stock
16 Dec 2019	Form 3: Myriam Curet, Director No securities owned
04 Dec 2019	Form 3: Northcott John, SVP & Chief Commercial Officer No securities owned
01 Oct 2019	Form 3: Zalevsky Jonathan, Chief R&D Officer Holds 220,657 shares of Common Stock
01 Oct 2018	Form 3: Eastham Karin, Director Holds 0 shares of Common Stock
21 Sep 2017	Form 3: Ajer Jeffrey Robert, Director Holds 0 shares of Common Stock
19 May 2014	Form 3: Gergel Ivan P., SVP Drug Development & CMO Holds 0 shares of Common Stock
11 Apr 2012	Form 3: Hora Maninder, SVP Pharma Dev and Mfg Holds 600 shares of Common Stock
11 Apr 2012	Form 3: Medve Robert, Chief Medical Officer
24 Mar 2010	Form 3: Ghosh Rinko, SVP and Chief Business Officer Holds 8,664 shares of Common Stock
03 Feb 2010	Form 3: Greer R Scott, Director Holds 40,000 shares of Common Stock
06 Jan 2010	Form 3: Doberstein Stephen K, Chief Scientific Officer
17 Dec 2009	Form 3: Winger Dennis L, Director Holds 0 shares of Common Stock
04 Dec 2009	Form 3: Lorianne Masuoka K., SVP & Chief Medical Officer
11 Aug 2008	Form 3: Moreadith Randall W, SVP Drug Development No securities owned
21 May 2008	Form 3: Chowrira Bharat M, COO & Head of PEGylation BU

Comments